Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$240M |
| 2 |
eBay
EBAY
|
+$231M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$216M |
| 4 |
Ameren
AEE
|
+$196M |
| 5 |
Kohl's
KSS
|
+$182M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$552M |
| 2 |
Micron Technology
MU
|
+$425M |
| 3 |
Visa
V
|
+$225M |
| 4 |
Marathon Petroleum
MPC
|
+$225M |
| 5 |
ESRX
Express Scripts Holding Company
ESRX
|
+$218M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 13.6% |
| 2 | Healthcare | 12.02% |
| 3 | Technology | 11.62% |
| 4 | Industrials | 11.19% |
| 5 | Consumer Discretionary | 10.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NVMI
2376
Nova
NVMI
$12.6B
| $1.76M | ﹤0.01% |
64,858
+56,339
| +661% | +$1.54M |
|
|
ESTR
2377
DELISTED
Estre Ambiental, Inc.
ESTR
| $1.76M | ﹤0.01% |
+175,820
| New | +$1.71M |
|
|
ABLX
2378
DELISTED
Ablynx NV
ABLX
| $1.75M | ﹤0.01% |
32,147
-483,142
| -94% | -$23.9M |
|
2379
eGain
EGAN
$183M
| $1.75M | ﹤0.01% |
219,927
+145,881
| +197% | +$968K |
|
2380
First Trust Global Tactical Commodity Strategy Fund
FTGC
$2.97B
| $1.75M | ﹤0.01% |
83,721
-29,014
| -26% | -$604K |
|
|
SP
2381
DELISTED
SP Plus Corporation
SP
| $1.75M | ﹤0.01% |
49,064
-49,300
| -50% | -$1.85M |
|
2382
Kroger
KR
$35.3B
| $1.74M | ﹤0.01% |
72,810
-719,022
| -91% | -$19.5M |
|
2383
KT
KT
$8.61B
| $1.74M | ﹤0.01% |
127,217
-278,681
| -69% | -$3.98M |
|
2384
Cavco Industries
CVCO
$4.15B
| $1.74M | ﹤0.01% |
9,995
-1,277
| -11% | -$211K |
|
2385
Invesco Preferred ETF
PGX
$3.81B
| $1.74M | ﹤0.01% |
118,883
+72,546
| +157% | +$1.06M |
|
|
MTSC
2386
DELISTED
MTS Systems Corp
MTSC
| $1.74M | ﹤0.01% |
33,600
-71,687
| -68% | -$3.71M |
|
2387
J. Jill
JILL
$263M
| $1.72M | ﹤0.01% |
92,564
+15,108
| +20% | +$484K |
|
|
ATRI
2388
DELISTED
Atrion Corp
ATRI
| $1.72M | ﹤0.01% |
2,719
+1,935
| +247% | +$1.13M |
|
|
ECYT
2389
DELISTED
Endocyte, Inc. Common Stock
ECYT
| $1.72M | ﹤0.01% |
188,931
-135,095
| -42% | -$745K |
|
|
CGNT
2390
DELISTED
Cogentix Medical, Inc.
CGNT
| $1.72M | ﹤0.01% |
446,048
+341,705
| +327% | +$1.07M |
|
2391
FedEx
FDX
$73.1B
| $1.71M | ﹤0.01% |
7,120
-298,516
| -98% | -$75.5M |
|
|
MYOK
2392
CALL
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $1.71M | ﹤0.01% |
+35,000
| New | +$1.82M |
|
|
RSO
2393
DELISTED
Resource Capital Corp.
RSO
| $1.71M | ﹤0.01% |
179,361
-51,856
| -22% | -$479K |
|
2394
CALL
Amgen
AMGN
$206B
| $1.71M | ﹤0.01% |
+10,000
| New | +$1.84M |
|
|
PETQ
2395
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $1.7M | ﹤0.01% |
64,022
-96,245
| -60% | -$2.25M |
|
2396
iShares MSCI Switzerland ETF
EWL
$2.17B
| $1.7M | ﹤0.01% |
49,526
+9,336
| +23% | +$332K |
|
2397
Q32 Bio
QTTB
$453M
| $1.7M | ﹤0.01% |
+5,051
| New | +$1.7M |
|
|
PTVCB
2398
DELISTED
Protective Insurance Corporation Class B Common Stock
PTVCB
| $1.7M | ﹤0.01% |
77,110
+29,757
| +63% | +$692K |
|
|
RCM
2399
DELISTED
R1 RCM Inc. Common Stock
RCM
| $1.69M | ﹤0.01% |
+237,036
| New | +$1.33M |
|
|
CO
2400
DELISTED
Global Cord Blood Corporation
CO
| $1.68M | ﹤0.01% |
164,781
+54,406
| +49% | +$556K |
|
Similar funds
Millennium Management's Q1 2018 Portfolio in Review
As of Q1 2018, Millennium Management held 4,417 positions worth $74.9B, up 3.4% from $72.5B the previous quarter. Its ten largest holdings account for 6.3% of the portfolio.
Millennium Management deployed $3.3B of net new capital in Q1 2018, opening 664 new positions and adding to 1,467 existing holdings. Its largest new stake was Tiffany & Co.: 1,078,847 shares worth $105M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $552M trimmed.
- Millennium Management's largest Q1 2018 buy was Tiffany & Co.: 1,078,847 shares worth $105M.
- Millennium Management added most to Boston Scientific in Q1 2018, an estimated $240M increase.
- Millennium Management's biggest Q1 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $552M.
- Millennium Management fully exited Equinix in Q1 2018, selling an estimated $152M.
- Millennium Management's ten largest holdings make up 6.3% of its $74.9B portfolio in Q1 2018.
- Millennium Management opened 664 new positions and closed 833 in Q1 2018.
- Millennium Management's portfolio value rose 3.4% quarter-over-quarter to $74.9B.
Based on Millennium Management's 13F filing for Q1 2018, filed 15 May 2018.